Advertisement
Screener

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MADRIGAL PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where MADRIGAL PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $189.55M went out.
  • Fiscal year ended 2025-12-31: from investing, $32.32M came in.
  • Fiscal year ended 2025-12-31: from financing, $255.98M came in.
  • Fiscal year ended 2025-12-31: change in cash, $98.76M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$189.55M$32.32M$255.98M*$98.76M
2024-12-31-$455.57M-$274.39M$735.06M*$5.10M
2023-12-31-$324.23M-$502.52M$595.12M*-$231.63M
2022-12-31-$224.86M$206.69M$313.45M*$295.28M
2021-12-31-$183.92M-$5.05M$171.24M*-$17.73M
2020-12-31-$157.56M$159.78M$5.09M*$7.31M
2019-12-31-$41.62M$30.71M-$10.68M
2018-12-31-$25.51M-$380.08M$314.33M*-$91.25M
2017-12-31-$22.32M-$22.01M$173.81M*$129.48M
2016-12-31-$17.61M$21.99M$5.95M$8.50M*$18.84M
2015-12-31-$3.14M$20.00M$6.00$3.30M*
2014-12-31-$78.92M-$8.84M$89.80M-$4.50M*
2013-12-31-$77.41M-$24.65M$38.73M$30.31M*
2012-12-31-$54.13M-$9.94M-$32.00K$66.25M$49.30M*
2011-12-31-$47.30M$9.33M$27.58M$9.15M*
2010-12-31-$38.20M-$19.80M$23.53M$21.63M*
2009-12-31-$26.81M$21.05M-$2.13M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30$23.33M*$34.20M*$3.11M*
2026-03-31-$167.44M$192.19M$2.33M$28.41M
2025-12-31-$133.46M*$27.58M*$8.96M*
2025-09-30$79.85M*-$207.00M*$236.65M*
2025-06-30-$47.05M*$47.86M*$1.74M*
2025-03-31-$88.89M$163.88M$8.64M$83.63M
2024-12-31-$104.49M*-$47.95M*$19.77M*
2024-09-30-$66.98M*-$202.39M*$7.46M*
2024-06-30-$134.94M*-$122.10M*$134.12M*
2024-03-31-$149.16M$98.05M$573.71M*$522.60M
2023-12-31-$79.93M*-$362.12M*$479.92M*
2023-09-30-$84.92M*$50.20M*$19.58M*
2023-06-30-$75.31M*-$3.73M*$42.93M*
2023-03-31-$84.07M-$186.86M$52.69M*-$218.24M
2022-12-31-$58.52M*$66.39M*$264.34M*
2022-09-30-$59.07M*$65.14M*$0.00*
2022-06-30-$57.36M*$19.24M*$49.11M*
2022-03-31-$49.91M$55.93M$6.01M
2021-12-31-$48.05M*$15.64M*$19.50M*
2021-09-30-$45.56M*$40.09M*$7.00K*$21.09M*
2021-06-30-$46.88M*-$27.32M*$63.54M*
2021-03-31-$43.43M-$33.46M$67.09M*-$9.80M
2020-12-31-$54.95M*-$4.80M*$4.63M*
2020-09-30-$47.85M*$94.75M*
2020-06-30-$24.26M*$19.36M*
2020-03-31-$30.51M$50.46M$19.95M
2019-12-31-$12.28M*-$30.51M*
2019-09-30-$11.32M*$28.27M*
2019-06-30-$11.54M*$36.44M*
2019-03-31-$6.48M-$3.49M-$9.89M
2018-12-31-$6.26M*$24.99M*$610.00K*
2018-09-30-$5.24M*-$222.03M*$451.00K*
2018-06-30-$5.36M*-$80.91M*$313.01M*
2018-03-31-$8.64M-$102.12M-$110.50M
2017-12-31-$5.95M*$6.08M*$135.53M*$135.67M*
2017-09-30-$4.95M*-$16.89M*-$21.84M*
2017-06-30-$7.65M*-$647.00K*$34.88M*
2017-03-31-$3.77M-$10.56M$3.40M
2016-12-31-$5.28M*$10.08M*$5.95M*$10.75M*
2016-09-30-$9.24M*$12.22M*$1.63M*$4.30M*
2016-06-30-$18.85M*-$22.69M*-$5.37M*
2016-03-31-$438.00K$22.38M$750.00K*
2015-12-31-$1.10M*$11.08M*-$36.94M*$38.29M*
2015-09-30$34.46M*$23.62M*$7.83M*-$43.07M*
2015-06-30-$17.73M*-$23.02M*$39.50M*
2015-03-31-$18.77M$8.32M-$2.31M*
2014-12-31-$19.21M*-$930.00K*$1.00K*-$2.31M*
2014-09-30-$18.57M*-$35.58M*$28.12M*-$2.31M*
2014-06-30-$20.87M*$11.48M*$51.55M*$2.62M*
2014-03-31-$20.27M$16.20M$10.12M-$2.50M*
2013-12-31-$18.69M*-$15.15M*$37.65M*$19.20M*
2013-09-30-$16.59M*$8.49M*$11.00K*
2013-06-30-$19.92M*$18.62M*$26.00K*
2013-03-31-$22.21M-$36.62M$1.04M$11.23M*
2012-12-31-$12.52M*$6.52M*$37.29M*$20.79M*
2012-09-30-$13.26M*-$6.84M*$158.00K*$23.79M*
2012-06-30-$13.10M*$3.70M*$598.00K*
2012-03-31-$15.25M-$13.32M$28.20M$4.85M*
2011-12-31-$10.49M*$19.99M*$87.00K*
2011-09-30-$11.82M*$6.71M*$20.00K*
2011-06-30-$12.15M*-$14.16M*$34.84M*
2011-03-31-$12.84M-$3.20M$2.10M*
2010-12-31-$8.21M*-$480.00K*$5.10M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05